February 24, 2025
Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and methylation, as well as a new multimodal data analysis platform Built on Illumina's powerful sequencers, new, disruptive omics solutions surpass industry standards forquality, scale, accuracy, and replicability SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) has unveiled a series of roadmap innovations, [...]
February 24, 2025
SAN DIEGO -- Singular Genomics Systems, Inc., an innovator in high-throughput spatial multiomics technologies designed to advance precision medicine, today announced key development milestones for its G4X™ Spatial Sequencer at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida. G4X Early Access Program Ongoing and Broader Availability on Track The G4X [...]
February 24, 2025
A. Preview of timsTOF Ultra 2 system with novel Athena Ion Processor (AIP): - Improves protein group identification in single-cell proteomics (SCP) by 15%-20%, and peptide identifications in SCP by 20%-25% -Advances immunopeptidomics with 15%-20% more immunopeptide identifications B. Launch of DeutEx™ software for hydrogen-deuterium exchange (HDX-MS) analysis C. OmniScape™ 2025b: a breakthrough in top-down protein sequencing software D. Advances in [...]
Nuclera appoints Seth Benson as Chief Financial Officer
February 24, 2025
Appointment to drive commercial growth of eProtein Discovery and support strategic expansion Cambridge, UK: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced that it has appointed Seth Benson as Chief Financial Officer. Seth joins CEO, Dr Michael Chen, on the executive team to advance commercial and strategic [...]
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
February 24, 2025
Officinae Bio's AI-driven sequence optimization expands Maravai's family of brands, enabling rapid, cost-effective nucleic acid therapy development SAN DIEGO -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced acquisition of Officinae Bio’s DNA and RNA business. This [...]
CIQTEK Delivered FESEM SEM5000X to Ilmenau University of Technology, Germany
February 24, 2025
CIQTEK, a leading provider of high-end scientific instruments, is delighted to announce the successful delivery of the SEM5000X Field Emission Scanning Electron Microscope to Ilmenau University of Technology in Germany. This marks a significant milestone for CIQTEK as it expands its presence in the global high-end scientific instrument market. The FESEM SEM5000X is a cutting-edge scanning electron microscope equipped with advanced field emission technology, [...]
Micromeritics and Fraunhofer ICT announce advanced electrochemistry collaboration
February 24, 2025
Norcross, Georgia, USA – Micromeritics Instrument Corporation, a Malvern Panalytical company, and Fraunhofer Institute for Chemical Technology ICT are pleased to announce a technical collaboration aimed at fostering the education and training of future scientists and engineers. This partnership is set to accelerate the development of novel materials critical for Cleantech applications, including thermochemical heat storage [...]
February 23, 2025
New single cell and spatial innovations extend 10x Genomics' technology and performance leadership across all three platforms PLEASANTON, Calif. -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a series of new product innovations to solidify its position as [...]
February 22, 2025
Expanded collaboration enables richer, more cost-effective biological insights from single cell workflows Oxford Nanopore Technologies announced today its expanded collaboration with 10x Genomics, Inc. to enable seamless compatibility between their latest technologies, bringing more accurate, cost-effective and accessible insights to single-cell transcriptomics research. The certified compatibility is between 10x Genomics’ latest Chromium Universal GEM-X 3’ and GEM-X [...]
February 21, 2025
BOSTON -- Volta Labs, a leading genomics applications company, and Ginkgo Bioworks, (NYSE: DNA), which is building a leading platform for cell programming and biosecurity, today announced the integration of the Callisto™ Sample Prep System at Ginkgo Bioworks as part of the routine Illumina sequencing workflow. "I like the Apps and the App Store concept on Callisto. It [...]

